Sartorius Stedim Biotech S.A. provided earnings guidance for fiscal 2020. the company projects that it will increase Group sales in fiscal 2020 on the basis of constant currencies by 10% to 13%, with the acquisition of Biological Industries, completed at the end of 2019, expected to contribute approximately 1.5% points to this growth.